ASPHD1 and neoplasm: The immunofluorescence results confirmed that xenografts in the ASPHD1 OE group exhibited elevated ASPHD1 expression levels compared with control tumors (Figures 9E, F), consistent with the reduced tumor burden observed in mice bearing ASPHD1-overexpressing xenografts.